Clinical Trial Update: Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 pilot evaluating neoadjuvant gemcitabine plus nab-paclitaxel (Abraxane) followed by surgery in pancreatic adenocarcinoma; the trial was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Adenocarcinoma Pancreas | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2015-11-09